Akums Drugs & Pharmaceuticals has announced the development of a DCGI-approved Clarithromycin + Vonoprazan + Amoxicillin ...
The conversation around environmental sustainability in the pharma industry is now expanding beyond the traditional ...
Biocon Biologics announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the granting of a marketing ...
Shilpa Biologicals, an integrated biologics development and manufacturing organisation, announces an exclusive Middle East ...
The injectable pharma landscape is becoming increasingly interconnected, with pharma companies, CDMOs, device manufacturers ...
Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup ...
Oncodesign Services and Nexus BioQuest have formed a partnership connecting their respective in vitro and in vivo expertise, ...
The Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) launched BIO-NIVESH ...
Congress 2026, AstraZeneca presented the design of the Phase IIb PRESTO trial, a large study set to evaluate whether AZD6793, ...
Dr. Reddy’s Laboratories announced a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences for ...
Alkem Laboratories announced the launch of NeuCeno (cenobamate), anti-seizure medication (ASM) for the treatment of ...
Indoco Remedies announced that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) inspected its solid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results